BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhou Z, Qi J, Zhao J, Lim CW, Kim JW, Kim B. Dual TBK1/IKKɛ inhibitor amlexanox attenuates the severity of hepatotoxin-induced liver fibrosis and biliary fibrosis in mice. J Cell Mol Med 2020;24:1383-98. [PMID: 31821710 DOI: 10.1111/jcmm.14817] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhou Z, Qi J, Lim CW, Kim JW, Kim B. Dual TBK1/IKKε inhibitor amlexanox mitigates palmitic acid-induced hepatotoxicity and lipoapoptosis in vitro. Toxicology 2020;444:152579. [PMID: 32905826 DOI: 10.1016/j.tox.2020.152579] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
2 Zhou Z, Qi J, Zhao J, Seo JH, Shin DG, Cha JD, Lim CW, Kim JW, Kim B. Orostachys japonicus ameliorates acetaminophen-induced acute liver injury in mice. J Ethnopharmacol 2021;265:113392. [PMID: 32946962 DOI: 10.1016/j.jep.2020.113392] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Zhou Z, Qi J, Yang D, Yang MS, Jeong H, Lim CW, Kim JW, Kim B. Exogenous activation of toll-like receptor 5 signaling mitigates acetaminophen-induced hepatotoxicity in mice. Toxicol Lett 2021;342:58-72. [PMID: 33571619 DOI: 10.1016/j.toxlet.2021.01.022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Zhou Z, Qi J, Kim JW, You MJ, Lim CW, Kim B. AK-1, a Sirt2 inhibitor, alleviates carbon tetrachloride-induced hepatotoxicity in vivo and in vitro. Toxicol Mech Methods 2020;30:324-35. [PMID: 32063085 DOI: 10.1080/15376516.2020.1729915] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Xiang S, Song S, Tang H, Smaill JB, Wang A, Xie H, Lu X. TANK-binding kinase 1 (TBK1): An emerging therapeutic target for drug discovery. Drug Discov Today 2021:S1359-6446(21)00248-8. [PMID: 34051368 DOI: 10.1016/j.drudis.2021.05.016] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Jiang Y, Chen S, Li Q, Liang J, Lin W, Li J, Liu Z, Wen M, Cao M, Hong J. TANK-Binding Kinase 1 (TBK1) Serves as a Potential Target for Hepatocellular Carcinoma by Enhancing Tumor Immune Infiltration. Front Immunol 2021;12:612139. [PMID: 33679751 DOI: 10.3389/fimmu.2021.612139] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Zhou Z, Qi J, Zhao J, Lim CW, Kim JW, Kim B. Dual TBK1/IKKɛ inhibitor amlexanox attenuates the severity of hepatotoxin-induced liver fibrosis and biliary fibrosis in mice. J Cell Mol Med 2020;24:1383-98. [PMID: 31821710 DOI: 10.1111/jcmm.14817] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]